(Health-NewsWire.Net, August 13, 2021 ) The global cell lysis market size is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 7.2% during the forecast period. Growth of the market is driven mainly by increasing government funding for research, high prevalence of diseases and growing focus on personalized medicine.
Browse 150 market data Tables and 40 Figures spread through 172 Pages and in-depth TOC on "Cell Lysis/Cell Fractionation Market"
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321
North America dominates the global cell lysis market
The cell lysis market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest share of the cell lysis market. The large share of North America can be attributed to factors such as the Growing stem cell and cancer research activities and the expanding biotechnology & pharmaceutical industries
Key Players of Market:
The major players in the cell lysis market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Danaher Corporation (US), Bio-Rad Laboratories (US), Cell Signaling Technology Inc. (US), Miltenyi Biotec (Germany), Roche Diagnostics (Switzerland), and QIAGEN N.V. (Netherlands).
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com
|